** Shares in French speciality chemicals company Arkema AKE.PA rise around 3.9% after its first-quarter results
** The company reports higher growth, around 15% compared with last year in key growth markets, namely batteries, sport, 3D printing and healthcare
** The demand improvement was likely aided by "pre-buying due to supply concerns from the Middle East conflict" alongside "strengthening commodity acrylics margins in China" J.P. Morgan analysts say
** Arkema confirms its 2026 outlook "while remaining vigilant about the potential impacts of the Middle East crisis on global demand"
(Reporting by Zakarya Meliani and Ronan Corcoran)
((zakarya.meliani@thomsonreuters.com))